When no sizeable carryover effects were being current, we analyzed info from equally phases of the crossover trial and present information from the primary period only for a sensitivity analysis. Carryover effects were being demonstrated for your LSAS but not for other outcomes in this trial (VAS, HDRS-17, STAI-S), and therefore knowledge from the